{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:46:39Z","timestamp":1785768399311,"version":"3.56.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T00:00:00Z","timestamp":1639872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.cardfail.2021.12.005","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T11:25:56Z","timestamp":1639826756000},"page":"778-786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5549-1298","authenticated-orcid":false,"given":"Job A.J.","family":"Verdonschot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00c3o Pedro","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pizard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Pellicori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Brunner La Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Cosmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Cuthbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5786-8121","authenticated-orcid":false,"given":"Olivia J.","family":"Waring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel H.T.M.","family":"Henkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Mariottoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Petutschnigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Hazebroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.F.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane R.B.","family":"Heymans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2021.12.005_bib0001","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0002","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.115.016801","article-title":"Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies","volume":"133","author":"Aune","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0003","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11154-014-9299-3","article-title":"Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk","volume":"15","author":"Mathieu","year":"2014","journal-title":"Rev Endocrine Metab Disord"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0004","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/ejhf.792","article-title":"Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial","volume":"19","author":"Olivier","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003350","article-title":"Associations of body mass index with laboratory and biomarkers in patients with acute heart failure","volume":"10","author":"Streng","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0006","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/eurheartj\/ehaa758","article-title":"The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart \u2018OMics\u2019 in AGEing (HOMAGE) randomized clinical trial","volume":"42","author":"Cleland","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0007","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/ejhf.1716","volume":"22","author":"Pellicori","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0008","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0009","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/CIRCULATIONAHA.117.032474","article-title":"Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity","volume":"137","author":"Packer","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0010","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/bph.13479","article-title":"Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats","volume":"173","author":"Youcef","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0011","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0012","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jchf.2016.11.015","article-title":"interaction between spironolactone and natriuretic peptides in patients with heart failure and preserved ejection fraction: from the TOPCAT Trial","volume":"5","author":"Anand","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0013","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jchf.2020.11.010","article-title":"Proteomic and mechanistic analysis of spironolactone in patients at risk for HF","volume":"9","author":"Ferreira","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0014","doi-asserted-by":"crossref","first-page":"449","DOI":"10.5414\/CNP72449","article-title":"Low-dose spironolactone, added to long-term ACE inhibitor therapy, reduces blood pressure and urinary albumin excretion in obese patients with hypertensive target organ damage","volume":"72","author":"Bomback","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5551\/jat.48710","article-title":"Fatty acid-binding protein 4 in cardiovascular and metabolic diseases","volume":"26","author":"Furuhashi","year":"2019","journal-title":"J Atheroscleros Thrombos"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0016","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.peptides.2007.03.005","article-title":"Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues","volume":"28","author":"Li","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0017","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/JOE-18-0174","article-title":"Chemerin: a multifaceted adipokine involved in metabolic disorders","volume":"238","author":"Helfer","year":"2018","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0018","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbadis.2013.05.009","article-title":"Direct and indirect effects of leptin on adipocyte metabolism","volume":"1842","author":"Harris","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0019","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.peptides.2005.02.017","article-title":"The role of adrenomedullin in angiogenesis","volume":"26","author":"Ribatti","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0020","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/ijms20051128","article-title":"Chemerin isoforms and activity in obesity","volume":"20","author":"Buechler","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/2277-9175.156526","article-title":"Leptin and its cardiovascular effects: focus on angiogenesis","volume":"4","author":"Tahergorabi","year":"2015","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0022","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2353\/ajpath.2008.080128","article-title":"Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis","volume":"173","author":"Krady","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0023","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","article-title":"Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma","volume":"192","author":"Kitamura","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0024","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ejhf.1366","article-title":"Adrenomedullin in heart failure: pathophysiology and therapeutic application","volume":"21","author":"Voors","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0025","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1194\/jlr.S091793","article-title":"Adipokine FABP4 integrates energy stores and counterregulatory metabolic responses","volume":"60","author":"Prentice","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0026","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/cvr\/cvx086","article-title":"New insights into the role of adipose tissue in thrombosis","volume":"113","author":"Vilahur","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0027","first-page":"4348","article-title":"Interacting hepatic PAI-1\/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity","volume":"130","author":"Zheng","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0028","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.RES.0000146031.94850.5f","article-title":"Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential","volume":"95","author":"Ribas","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0029","doi-asserted-by":"crossref","unstructured":"Shih DM, Xia YR, Wang XP, Wang SS, Bourquard N, Fogelman AM, et al. Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice. Circ Res 2007;100:1200\u20137. https:\/\/doi.org\/10.1161\/01.Res.0000264499.48737.69","DOI":"10.1161\/01.RES.0000264499.48737.69"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0030","doi-asserted-by":"crossref","unstructured":"Haywood NJ, Slater TA, Matthews CJ, Wheatcroft SB. The insulin like growth factor and binding protein family: novel therapeutic targets in obesity & diabetes. Mol Metab 2019;19:86\u201396. https:\/\/doi.org\/10.1016\/j.molmet.2018.10.008","DOI":"10.1016\/j.molmet.2018.10.008"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0031","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1210\/jc.2011-1497","article-title":"The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans","volume":"96","author":"Charles","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cardfail.2021.12.005_bib0032","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00125-008-1075-z","article-title":"Increased fat:carbohydrate oxidation ratio in Il1ra (-\/-) mice on a high-fat diet is associated with increased sympathetic tone","volume":"51","author":"Chida","year":"2008","journal-title":"Diabetologia"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916421005017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916421005017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:47:32Z","timestamp":1761029252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916421005017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1071916421005017"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.12.005","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}